Terms ending in 2043
Every in-force patent on Phio Pharmaceuticals Corp.'s record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,753,407 | Chemically Modified Oligonucleotides Targeting Bromodomain Containing Protein 4 (BRD4) for Immunotherapy In force · High confidence | Phio Pharmaceuticals Corp. | In force | High confidence |
1 of 1 patent shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.